首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1390829

犬異位性皮膚炎市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Canine Atopic Dermatitis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月24日 | 出版商:

IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年，全球犬異位性皮膚炎市場規模達到18億美元。展望未來， IMARC Group預計到2028年市場規模將達到44億美元，2022-2028年複合年成長率（CAGR）為16.06%。

犬異位性皮膚炎（CAD）是一種由花粉、室內灰塵、昆蟲叮咬、草和食物成分等過敏原引起的犬過敏性皮膚病。這是一種遺傳傾向，通常影響六個月至三歲的狗。它通常影響動物的腹側腹部、口腔、眼睛、指間皮膚、耳廓、腕骨、肘部和會陰區域。 CAD 的特徵是出現各種症狀，例如過度抓癢、爪子、腋下和臉部周圍發炎和搔癢。可以透過免疫抑制劑、單克隆解剖學和糖皮質激素來治療。它們可以透過口服、注射和局部用藥的方式給藥。眾所周知，它在德國牧羊犬、拉布拉多犬、金毛獵犬和哈巴狗中非常普遍。

犬異位性皮膚炎市場趨勢：

全球範圍內家犬中 CAD 的發生率不斷增加，這是創造積極市場前景的關鍵因素之一。這可以歸因於環境條件的變化、空氣污染水平的上升以及長期接觸過敏原。此外，寵物主人對 CAD 早期症狀和體徵（如發紅、皮膚油膩和酵母氣味）的日益關注和認知不斷提高，正在推動市場成長。此外，單株抗體治療該疾病的廣泛採用也有利於市場成長。這些抗體有助於指導所需的免疫反應並平息疾病的傳播。與此一致的是，越來越多的獸醫、醫院和診所致力於為動物提供更好的護理，這對市場成長產生了積極影響。其他因素，包括政府實施各種限制在動物身上使用標籤外人類藥物的舉措，以及獸醫科學領域的廣泛研究和開發（R＆D），預計將推動市場成長。

本報告回答的關鍵問題：

迄今為止，全球犬異位性皮膚炎市場表現如何，未來幾年又將如何表現？
COVID-19 對全球犬異位性皮膚炎市場有何影響？
主要區域市場有哪些？
根據藥物類別類型的市場細分是什麼？
根據給藥途徑，市場的分化為何？
基於配銷通路的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球犬異位性皮膚炎市場的結構如何？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 10 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 13 章：價格分析

第14章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- AB Science
- Bimeda Inc.
- Bioceltix SA
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Incorporated
- Phibro Animal Health Corporation
- Toray Industries Inc.
- Vetoquinol SA
- Virbac
- Zoetis Inc.

簡介目錄圖表

Product Code: SR112023A4700

Abstract

The global canine atopic dermatitis market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.06% during 2022-2028.

Canine atopic dermatitis (CAD) is an allergic skin disease in dogs caused by allergens, such as pollens, house dust, insect bites, grass and food ingredients. It is an inherited predisposition that generally affects dogs aged between six months to three years. It commonly affects the ventral abdomen, mouth, eyes, interdigital skin, ear pinnae, carpal, elbow and perineal area of the animals. CAD is characterized by various symptoms, such as excessive scratching, inflammation and itching around paws, underarms and face. It can be treated by immuno-suppressants, monoclonal anatomy and glucocorticoids. They can be administered through oral, injectables and topical medications. It is known to be highly prevalent in German shepherds, Labradors, golden retrievers and pugs.

Canine Atopic Dermatitis Market Trends:

The increasing occurrence of CAD in domesticated dogs across the globe is one of the key factors creating a positive outlook for the market. This can be attributed to the changing environmental conditions, rising air pollution levels and prolonged exposure to allergens. Moreover, the increasing concerns and rising awareness among pet owners regarding early symptoms and signs of CAD, such as redness, greasy skin and yeasty smell, are providing a thrust to the market growth. Additionally, the widespread adoption of monoclonal antibodies for the treatment of the disease is favoring the market growth. These antibodies aid in directing the required immune response and calming the spread of the disease. In line with this, the increasing number of veterinary practitioners, hospitals and clinics dedicated to providing improved care for animals is positively impacting the market growth. Other factors, including the implementation of various government initiatives to restrict the usage of off-label human drugs on animals, along with extensive research and development (R&D) in the field of veterinary sciences, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global canine atopic dermatitis market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class type, route of administration and distribution channel.

Breakup by Drug Class Type:

Glucocorticoids

Immunosuppressants

Monoclonal Antibody

Others

Breakup by Route of Administration:

Topical

Oral

Injectable

Breakup by Distribution Channel:

Veterinary Hospitals

Pet Clinics

Pharmacies and Drugstores

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Bimeda Inc., Bioceltix SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Toray Industries Inc., Vetoquinol S.A., Virbac and Zoetis Inc.

Key Questions Answered in This Report:

How has the global canine atopic dermatitis market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global canine atopic dermatitis market?
What are the key regional markets?
What is the breakup of the market based on the drug class type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global canine atopic dermatitis market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Canine Atopic Dermatitis Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class Type

6.1 Glucocorticoids
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Immunosuppressants
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Monoclonal Antibody
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Route of Administration

7.1 Topical
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Oral
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Injectable
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Veterinary Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Pet Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Pharmacies and Drugstores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 AB Science
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
- 14.3.2 Bimeda Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Bioceltix SA
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
- 14.3.4 Boehringer Ingelheim International GmbH
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Ceva Sante Animale
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Dechra Pharmaceuticals PLC
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
- 14.3.7 Elanco Animal Health Incorporated
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
- 14.3.8 Phibro Animal Health Corporation
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Toray Industries Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Vetoquinol S.A.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
- 14.3.11 Virbac
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Zoetis Inc.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Canine Atopic Dermatitis Market: Major Drivers and Challenges
Figure 2: Global: Canine Atopic Dermatitis Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Canine Atopic Dermatitis Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Canine Atopic Dermatitis Market: Breakup by Drug Class Type (in %), 2022
Figure 5: Global: Canine Atopic Dermatitis Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Canine Atopic Dermatitis Market: Breakup by Distribution Channel (in %), 2022
Figure 7: Global: Canine Atopic Dermatitis Market: Breakup by Region (in %), 2022
Figure 8: Global: Canine Atopic Dermatitis (Glucocorticoids) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Canine Atopic Dermatitis (Glucocorticoids) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Canine Atopic Dermatitis (Immunosuppressants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Canine Atopic Dermatitis (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Canine Atopic Dermatitis (Monoclonal Antibody) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Canine Atopic Dermatitis (Other Drug Class Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Canine Atopic Dermatitis (Topical) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Canine Atopic Dermatitis (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Canine Atopic Dermatitis (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Canine Atopic Dermatitis (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Canine Atopic Dermatitis (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Canine Atopic Dermatitis (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Canine Atopic Dermatitis (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Canine Atopic Dermatitis (Pet Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Canine Atopic Dermatitis (Pet Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Canine Atopic Dermatitis (Pharmacies and Drugstores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Canine Atopic Dermatitis (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia-Pacific: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia-Pacific: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Canine Atopic Dermatitis Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Canine Atopic Dermatitis Market: Breakup by Country (in %), 2022
Figure 78: Middle East and Africa: Canine Atopic Dermatitis Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Global: Canine Atopic Dermatitis Industry: SWOT Analysis
Figure 80: Global: Canine Atopic Dermatitis Industry: Value Chain Analysis
Figure 81: Global: Canine Atopic Dermatitis Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Canine Atopic Dermatitis Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Drug Class Type (in Million US$), 2023-2028
Table 3: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 5: Global: Canine Atopic Dermatitis Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Canine Atopic Dermatitis Market: Competitive Structure
Table 7: Global: Canine Atopic Dermatitis Market: Key Players

02-2729-4219

+886-2-2729-4219